https://igaku-yorozu.com 2026-07-05T12:35:02.115Z weekly 1 https://igaku-yorozu.com/articles/thyroid-disease-women 2026-07-05T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/next-gen-anti-obesity-drugs-beyond-glp1 2026-06-29T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/iron-deficiency-anemia-women-fatigue 2026-06-28T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/gsm-genitourinary-syndrome-menopause 2026-06-26T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/liquid-biopsy-ctdna-monitoring-2026 2026-06-25T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/rapamycin-mtor-longevity 2026-06-25T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/postpartum-depression-support-science 2026-06-16T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/vascular-age-atherosclerosis-cardiovascular-risk 2026-06-15T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/uv-photoaging-skin-protection 2026-06-13T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/male-infertility-sperm-quality 2026-06-09T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/pelvic-organ-prolapse-urinary-incontinence 2026-06-08T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/epigenetic-age-dna-methylation-clock-2026 2026-06-06T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/prostate-cancer-screening 2026-06-05T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/nocturnal-enuresis-bedwetting-children-science 2026-06-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/vitamin-d-light-and-shadow 2026-05-30T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/cognitive-decline-prevention 2026-05-23T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/childhood-myopia-control-science 2026-05-21T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/pms-pmdd-premenstrual-syndrome-treatment-science 2026-05-23T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/mitochondria-aging-energy-factory-strategy 2026-05-23T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/ai-copilot-clinic-future-medicine 2026-05-13T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/masld-fatty-liver-new-national-disease 2026-05-12T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/orthostatic-dysregulation-children-morning-rise-science 2026-05-11T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/childhood-atopic-dermatitis-treatment-skincare-science 2026-05-08T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/bone-density-osteoporosis-prevention-strategy 2026-05-07T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/pcos-polycystic-ovary-syndrome 2026-05-06T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/bph-benign-prostatic-hyperplasia-nocturia-science 2026-05-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/developmental-disorders-asd-adhd-early-detection 2026-05-03T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/sarcopenia-prevention-muscle-longevity 2026-05-03T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/testosterone-mens-health-multifaceted-role 2026-04-29T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/medical-llm-clinical-reasoning-agentclinic-2026 2026-04-28T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/infertility-ivf-egg-freezing-pgt-frontline-2026 2026-04-26T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/fphl-female-pattern-hair-loss-treatment-guide 2026-04-25T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/loh-syndrome-male-menopause-diagnosis-treatment 2026-04-25T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/menopause-comprehensive-guide-2025 2026-04-25T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/genetic-testing-precision-medicine-genomics-2026 2026-04-24T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/intermittent-fasting-longevity-best-hours 2026-04-23T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/mitochondrial-transplantation-regenerative-medicine-2026 2026-04-22T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/inflammaging-chronic-inflammation-aging 2026-04-21T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/ed-erectile-dysfunction-vascular-disease 2026-05-08T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/menstrual-migraine-hormones-treatment-guide 2026-04-17T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/child-food-allergy-early-introduction-oit-guide 2026-04-11T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/alzheimer-lecanemab-new-era-2026 2026-04-10T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/glp1-anti-aging-beyond-obesity-2026 2026-04-08T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/ai-diagnostic-imaging-vs-physicians-2026 2026-04-07T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/endometriosis-pain-treatment-guide 2026-04-07T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/gut-microbiome-aging-science-2026 2026-04-05T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/child-height-growth-science-strategy 2026-04-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/nad-nmn-supplement-science-2026 2026-04-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/telomere-aging-science-strategy-2026 2026-04-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/sleep-aging-science-young-sleep 2026-04-03T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/ectopic-mongolian-spot-laser-treatment-timing 2026-04-02T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/wearable-preventive-medicine-cgm-sleep-ecg 2026-04-02T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/exosome-therapy-evidence-guide-2026 2026-04-01T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/senolytics-longevity-science-frontiers-2026 2026-04-01T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/hair-graying-science-canities-guide 2026-03-31T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/cancer-screening-evidence-2026 2026-04-27T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/aga-complete-guide-30s-40s-men 2026-04-02T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/positional-skull-deformities 2026-03-29T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/skin-antiaging-evidence-based-guide 2026-03-29T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/articles/sids 2026-04-23T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/categories/%E3%82%A6%E3%82%A4%E3%83%A1%E3%83%B3%E3%82%BA%E3%83%98%E3%83%AB%E3%82%B9 2026-07-05T12:35:02.115Z weekly 0.6 https://igaku-yorozu.com/categories/%E6%9C%AA%E6%9D%A5%E3%81%AE%E5%8C%BB%E7%99%82 2026-07-05T12:35:02.115Z weekly 0.6 https://igaku-yorozu.com/categories/%E3%82%A2%E3%83%B3%E3%83%81%E3%82%A8%E3%82%A4%E3%82%B8%E3%83%B3%E3%82%B0 2026-07-05T12:35:02.115Z weekly 0.6 https://igaku-yorozu.com/categories/%E3%83%A1%E3%83%B3%E3%82%BA%E3%83%98%E3%83%AB%E3%82%B9 2026-07-05T12:35:02.115Z weekly 0.6 https://igaku-yorozu.com/categories/%E3%81%93%E3%81%A9%E3%82%82%E3%81%AE%E6%82%A9%E3%81%BF 2026-07-05T12:35:02.115Z weekly 0.6 https://igaku-yorozu.com/soudan 2026-07-05T12:35:02.115Z weekly 0.8 https://igaku-yorozu.com/soudan/hidden-iron-deficiency-no-anemia 2026-07-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/soudan/menopause-sudden-gsm-symptoms 2026-07-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/soudan/retatrutide-personal-import 2026-07-04T00:00:00.000Z monthly 0.8 https://igaku-yorozu.com/newsletter 2026-07-05T12:35:02.115Z weekly 0.7 https://igaku-yorozu.com/newsletter/prostate-cancer-estradiol-patch-new-era-2026 2026-04-25T00:00:00.000Z monthly 0.6 https://igaku-yorozu.com/evidence 2026-07-05T12:35:02.115Z weekly 0.7 https://igaku-yorozu.com/evidence/bao-2026-exhaustive-exercise-biomarkers 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shen-2026-vitamin-d-telomere-meta 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kumar-2026-epigenetics-gut-brain-axis 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tippairote-2026-mitochondria-telomere-axis 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/christen-2026-nad-boosters-comparison 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jacobs-2026-simflow-medical-education 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nakazzi-2026-vitamin-b3-cancer 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/exosome-skin-rejuvenation-sr-2026 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hehir-2026-5ari-turp-ma 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rajendran-2026-femi-ai-embryo 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fda-2026-ai-enabled-devices 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/physiotherapy-endometriosis-2026-sr 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/du-2026-encapsulated-mitochondria-cell 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ayupov-2026-mitocatch-targeted-transplantation 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-m-2026-nmn-blood-pressure 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ncc-2026-cancer-gene-panel-realworld 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ran-2026 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liao-2026-cgm-nondiabetic-meta 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garcia-becerra-2026-trt-cv-prostate-meta 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yeap-2026-testosterone-cv-health-review 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pan-2026 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/maunder-2025-ims-complementary-therapies 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/corona-2026-glp1ra-testosterone 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shimasaki-2026-lecanemab-japan-rwd 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/swanson-2026-lecanemab-apoe4-homo 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chen-2026-lecanemab-safety-srma 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/robb-2026-ptau217-adoption 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/demattos-2026-amyloid-pet-outcomes 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/guldan-2026 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/guizzaro-2026-ema-assessment 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hoilund-carlsen-2026-antiamyloid-doubts 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/beebeejaun-2026-trigger-high-responders 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/grundberg-2026-stockholm-plus-ldct 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mccully-2026-mitochondrial-transplantation-kidney 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/marlow-2026-mced-diagnostic-experience 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2026-mitochondrial-transplantation-ra 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-d-2026-mitochondrial-transfer-diabetes 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2026-nma 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gupta-2026-ldom-delphi-consensus 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/floyd-2026-time-restricted-eating-pcos 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/grammenou-2026-ivf-psychological-gender 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ritter-2026-water-iii-rct 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/neven-2026-pcos-global-prevalence 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zheng-2026-exercise-depression-pcos 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/forslund-2026-glp1-pcos-meta-analysis 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lu-2026-liraglutide-pcos-meta-analysis 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/samarasinghe-2026-weight-loss-ovulation-pcos 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rao-2026-prime-llm-clinical-reasoning 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sugiyama-2026-od-japanese-adenylate-cyclase 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jma-2026-ai-clinical-ethics-recommendation 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sharma-2026-enuresis-review 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jp-pop-surgery-insurance-2026 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lemos-2026-vaginal-dhea-meta 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/savas-2026-beyond-weight-loss-multisystem 2026-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hauglund-2025-glymphatic-sleep 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chen-2025-sleep-telomere-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sobral-2025-oral-vs-topical-minoxidil-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/aguilar-toala-2025-retinoids-network-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fernandez-garza-2025-growth-hormone-aging 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schooling-2025-telomere-lifespan-mr 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mendy-2025-epigenetic-mortality-us 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sanchez-gonzalez-2025-exercise-telomere-umbrella 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ryall-2025-aerobic-fitness-telomere-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fuentealba-2025-plasma-exchange 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wattanathorn-2025-anthocyanin-telomere-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-l-2025-nad-clinical-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sun-2025-exercise-telomere-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yu-2025-aipatient-simulated 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lawrenson-2025-cochrane-nma-update 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/prokopidis-2025-nmn-nr-muscle 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/franco-2025-mist-bph-sr 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/millar-2025-stamina-senolytics-cognition 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kraig-2025-pearl-rapamycin 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/takao-2025-ap2a1-senescence 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zheng-2025-senolytics-senomorphics-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/exosome-diabetic-wound-ma-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yoham-2025-tretinoin-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/exosome-spinal-cord-ma-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/song-2025-prp-exosome-knee-oa 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sinclair-2025-ldom-consensus 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mccartney-2025-epigenetic-clocks-comparison 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shan-2025-llm-diagnostic-accuracy-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lambrinoudaki-2025-ims-hrt-recommendations 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jswm-2025-hrt-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jla-2025-lung-screening-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cappon-2025-cgm-cardiovascular-prevention 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dimova-2025-noninvasive-cgm-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/aritake-okada-2025-sleep-wearable-validation 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kim-2025-apple-watch-ecg-af-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/iqhrammullah-2025-smartwatch-ecg-ppg-af 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jhrs-jcs-2025-wearable-ecg-consensus 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shelley-2025-pgs-iss 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jrs-2025-ai-management-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-vos-2025-smartwatch-af-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2025-dr-ai-screening 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/npj-2025-approved-dr-systems 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tb-ai-2025-cxr-software 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nejati-bervanlou-2025-exercise-protein-inflammaging 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2025-sleep-disorders-aging-mr 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lang-2025-masai-mammography 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/guo-2025-generative-ai-physicians 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nurmatov-2025-biologics-food-allergy 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/calli-2025-ai-generalizability 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-y-2025-minoxidil-finasteride-combo-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cayan-2025-varicocele-noa 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/xu-2025-nursing-infertility-anxiety 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yu-2025-dutasteride-tamsulosin-ma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hashmi-2025-tamsulosin-tadalafil-ma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mohri-2025-graying-melanoma-antagonism 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/as-sanie-2025-endometriosis-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dienogest-vs-coc-2025-efficacy 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/endometriosis-pain-course-2025-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cochrane-2025-progestagens-endometriosis 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dienogest-vs-gnrh-2025-surgery 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gnrh-nma-2025-second-line 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-almeida-2025-ha-fillers-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cummings-2025-evoke-semaglutide-alzheimer 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/relugolix-2025-ehp30-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/neta-vs-dienogest-2025-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gomez-llerena-2025-central-sensitization 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2025-sleep-dna-methylation-china 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/alz-association-treatment-info 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cngof-2025-pelvic-pain-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/delaire-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ballesio-2025-sleep-deprivation-inflammation-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mcguire-2025-soul-oral-semaglutide-cv 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jakubowska-2025-gepants-cgrp 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kubat-2025-biotechnological-mitochondria-transfer 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/exosome-hair-sr-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/exosome-plant-hair-rct-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lewis-2025-cerebral-palsy-genomic-sr 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2025-sleep-brain-age-inflammation 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2025-glp1ra-cv-kidney-meta-analysis 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/xia-2025-minoxidil-combination-nma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zeng-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kim-2025-llm-inflexible-reasoning 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/leavitt-2025-female-hair-loss-nonpharm 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mohan-2025-exosome-clinical-trials 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liang-2025-global-myopia-projection 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bofill-2025-cochrane-long-term-hrt 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/eau-2025-sexual-reproductive-health 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yoshimura-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/brouard-2025-visual-exposome-infant-sleep 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cardoso-2025-elinzanetant-oasis4-breast-cancer 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-silva-2025-hh-bmd-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nikkhah-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hara-yamamoto-2025-elderly-wearable 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cxr-ai-2025-pneumonia-lungcancer 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mendonca-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yamashita-2025-vitamin-d-japanese-students 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dienogest-vs-ocp-2025-pain-qol 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dyer-2025-cochrane-falls-care-facilities 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pmda-2025-samd-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vandyck-2025-lecanemab-ole-36m 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mintun-2025-donanemab-ole 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chen-2025-inflammageing-biomarkers-mortality 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sanyal-2025-semaglutide-mash-phase3 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2025-bcaa 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tailor-2025-ai-summary-ophthalmology-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/low-dose-dienogest-2025-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/otani-2025-japan-ed-prevalence 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gpt-radiology-2025-differential 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/asgari-2025-llm-hallucination-framework 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/perneczky-2025-antiamyloid-patient-characteristics 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cheng-2025-immunotherapy-nma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/beaudart-2025-pth1-agonists-nma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/luccioli-2025-anaphylaxis-children 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gbd-2025-headache-burden 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/robinson-2025-nutrition-pms 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/takeda-2025-kampo-pms-pmdd 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/huang-2025-mindfulness-inflammaging 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhao-2025-optimal-rt-bmd 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/farr-2025-senescent-biomarkers-clinical-trials 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/brestoff-2025-mitochondria-nomenclature-consensus 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-m-2025-engineered-mitochondria-diseases 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lukac-2025-ambient-ai-scribe-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/caudle-2025-cpic-summary 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsscf-2025 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gbd-2021-asd-epidemiology 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/khera-2025-icsm-2024-hypogonadism 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zitzmann-2025-traverse-european-position 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kaufman-2025-aua-gsm-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lin-2025-pgta-severe-male-infertility 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/har-2025-cancer-screening-preferences-sr 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tordjman-2025-deepseek-medical-benchmark 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sounderajah-2025-stard-ai-guideline 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fda-2025-ai-enabled-medical-devices 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kucking-2025-ai-recommendation-diagnostic 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/budzyn-2025-endoscopist-deskilling-ai 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2025-genai-mental-health 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ostinelli-2025-adhd-adult-nma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/singh-2025-exercise-cognition-umbrella 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/josteo-2025-guideline-japan 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsog-2025-art-databook-2023 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gbd-2025-atopic-dermatitis-burden 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/el-idrissi-2025-ad-qol 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/matsui-2025-pots-family-personality 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/higuchi-2025-secondary-headache-pediatric 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kamei-2025-japan-myopia-ndb 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/santen-2025-ryjusea-japan-approval 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/souza-2025-mash-network-meta 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2025-hcc-umbrella 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gbd-2023-metabolic-risk-burden 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/olson-2025-ambient-ai-burnout-reduction 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shah-2025-stanford-ai-scribe-pilot 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/huo-2025-llm-chatbot-systematic-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/busch-2025-patient-attitudes-ai 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/permanente-2025-ambient-ai-2-5m-uses 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tahhan-2025-imi-digest 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/japan-myopia-society-2025-atropine-guide 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wspos-2025-myopia-consensus 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/baker-2025-us-pointer-multidomain-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/grant-2025-vitamin-d-evidence-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wimalawansa-2025-vitamin-d-trial-design 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhai-2025-enuresis-pharmacological-nma 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cammisa-2025-enuresis-management 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/raychaudhuri-2025-prostate-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/abdel-fattah-2025-future-urodynamics 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/szabo-2025-lifestyle-environmental-fertility 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tie-2025-dynamic-5yr-ctdna 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tie-2025-dynamic3-stage3-colon 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fukumoto-2025-realworld-ctdna-japan 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ruiz-torres-2025-ctdna-head-neck 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/moel-2025-rapamycin-mtor 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ippolito-2025-vaginal-laser-sui-cochrane 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ozaki-2025-genja-luts-sexual 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ogawa-2025-gsm-anxiety-depression 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jaber-2025-laser-breast-cancer-rct 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/auerbach-2025-iron-deficiency-adults-review 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/richardson-2025-ferritin-inflammation-marrow 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kadowaki-2025-surmount-j-japanese 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yokote-2025-surmount-j-subgroup 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/abdrabou-2025-retatrutide-meta-analysis 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garvey-2025-cagrisema-redefine1 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/davies-2025-cagrisema-redefine2-t2dm 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jastreboff-2025-maritide-phase2 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/horn-2025-orforglipron-attain2 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wharton-2025-oral-semaglutide-25mg-oasis4 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kadowaki-2025-oral-semaglutide-oasis2-east-asian 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dahl-2025-amycretin-phase1b2a 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kuhre-2025-amycretin-preclinical 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/piekielko-2025-thyroid-cognition 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/osinga-2025-thyroid-gdm 2025-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-j-2024-nmn-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/penha-2024-oral-vs-topical-minoxidil-rct 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/paus-2024-hair-graying-revisited 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2024-sleep-guide 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fazekas-2024-mri-screening-srma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/loomba-2024-tirzepatide-mash 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/souza-talarico-2024-stress-telomere-sr 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/novelle-2024-fmt-longevity-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chen-la-2024-gut-microbiome-elderly 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/morifuji-2024-nmn-elderly-japan 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yamaguchi-2024-nmn-japanese-men 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/van-hul-2024-healthy-gut-microbiome 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chaib-2024-senolytics-senomorphics-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gupta-2024-exosome-hair-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wen-2024-nmn-physical-performance 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/crespo-garcia-2024-epigenetic-clocks-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsrm-2024-exosome-guidance 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2024-exosome-notice 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nadeeshani-2024-ageing-pathology-consensus 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/johansson-2024-hrt-cardiovascular-bmj 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pinkerton-2024-elinzanetant 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ncc-japan-cancer-screening-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/manson-2024-whi-practice 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/richardson-2024-cgm-behaviour-change-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ajoolabady-2024-immunosenescence-inflammaging 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mendez-2024-fitbit-garmin-whoop-sleep 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jspe-2024-growth-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jespersen-2024-ssri-pms-pmdd 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2024-dietary-reference-intakes 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cfa-2024-infant-growth-survey 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kucharska-2024-gh-syndromes-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/savarirayan-2024-vosoritide-phase3 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/haggenmuller-2024-skin-cancer-ai 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/haggenmuller-2024-human-ai-interaction 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jabbour-2024-fair-ai-limits 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/arunachalam-2024-digital-pathology-ai 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fujita-2024-exosome-regulation 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/milad-2024-gpt4-ophthalmology 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cheng-2024-sleep-duration-biological-aging 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/orourke-2024-nrf2-ho1-inflammaging 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/katsuumi-2024-sglt2-senolytics 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2024-semaglutide-alzheimer-realworld 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pencina-2024-traverse-sexual-function 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/perkovic-2024-flow-semaglutide-ckd 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/packer-2024-tirzepatide-hfpef 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/singh-2024-aging-inflammation 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsog-2024-endometriosis-protocol 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/du-toit-2024-leap-adolescence 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/whaikid-2024 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-matteis-2024-menstrual-migraine 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zong-2024-mitochondrial-dysfunction-therapy 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kim-2024-sids-umbrella-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yongpisarn-2024-vitamin-d-alopecia 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kamishima-2024-maga-fphl-trichoscopy 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chervova-2024-epigenetic-clocks-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/xu-2024-trt-erectile-prostate-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yuan-2024-trt-luts-nma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yao-2024-glp1ra-network-meta-analysis 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/snyder-2024-traverse-fractures 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hemachandra-2024-menopause-guidelines-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chlebowski-2024-whi-ovarian-endometrial 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/danan-2024-gsm-treatment-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cfa-2024-sids-awareness-month 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/morga-2024-fezolinetant-nma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sequeira-2024-prostate-liquid-biopsy-sr 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kistler-fischbacher-2024-do-health-bone 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shah-2024-vitamin-d-systematic-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2024 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/uleri-2024-thufep-holep-ma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wilbon-2024-glp1ra-beyond-obesity-diabetes 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/katzman-2024-pneumothorax-dl 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ihara-2024-pms-antenatal-depression 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/miner-2024-princeton-iv 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/adefegha-2024-oxidative-stress-ed 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mou-2024-pde5i-cv-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/anderson-2024-tadalafil-cv-cohort 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sokolakis-2024-liswt-cochrane 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mantovani-2024-lecanemab-srma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nexha-2024-biological-rhythms-pms 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2024-sasp-implications 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/farr-2024-senolytic-bone-metabolism 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jpeds-2024-safe-sleep-statement 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yoosuf-2024-alpha-blocker-nma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kobayashi-2024-denosumab-vs-bp 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bhasin-2024-traverse-depression 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/morgentaler-2024-androgen-society-trt-mace 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gu-2024-mht-cardiovascular-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yoshimi-2024-japan-pms-practice 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schmidgall-2024-agentclinic 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/holderried-2024-gpt4-simulated-patient 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/preiksaitis-2024-llm-emergency-medicine 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/santos-2024-asd-screening-diagnosis 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sandhu-2024-aua-bph-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/reilly-2024-pmdd-prevalence 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/suzuki-2024-bph-cvd-cohort 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fu-x-2024-mets-bph-molecular-sr 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/helvaci-2024-pcos-metabolic-disease 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsog-2024-pcos-diagnostic-criteria-japan 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hirsch-2024-planned-oocyte-cryopreservation 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fuse-nagase-2024-university-pmdd-recognition 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kirubarajan-2024-return-rates-oocyte 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garratt-2024-vitrified-oocyte-15year 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/migliavaca-2024-ad-prevalence-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/grondal-2024-escitalopram-pmdd-aggression 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lax-2024-topical-antiinflammatory-nma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/boothe-2024-ad-pathophysiology 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lin-2024-dupilumab-atopic-march 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/paller-2024-dupilumab-1year-infants 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/silverberg-2024-nemolizumab-arcadia 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hebert-2024-lebrikizumab-adolescent 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jspp-od-official-information 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sakata-2024-od-children-qt-interval 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jspp-od-alternative-therapy-statement 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/en-li-cho-2024-t2dm-masld-prevalence 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kamada-2024-metald-fibrosis-risk 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sakai-2024-nagala-t2dm-incidence 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/harrison-2024-maestro-nash 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/malik-2024-sarcopenia-masld 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-2024-pediatric-mafld-consensus 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/suvarna-2024-resmetirom-meta 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/newsome-2024-essence-design 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/seikatsusyukanbyo-2024-nafld-japan-epidemiology 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsge-2024-nomenclature-statement 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wan-2024-nurse-llm-outpatient-rct 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yamamoto-2024-ai-medical-interview-japan 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/who-2024-lmm-ethics-governance 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ubie-2024-generative-ai-hospitals 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mizuno-2024-yakumo-mtdna-mortality 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yam-2024-lamp-phase4 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nli-2024-insurance-coverage-infertility 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/easl-easd-easo-2024-masld-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsog-2024-pmd-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cary-2024-pmd-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/laughton-2024-cypress-dot-4year 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ostrin-2024-rlrl-safety 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/livingston-2024-lancet-dementia-prevention-14factors 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sakurai-2024-j-mint-japanese-multidomain 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/oki-2024-j-mint-prime-tamba 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nucci-2024-mediterranean-diet-dementia-ma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jones-2024-modifiable-risk-dementia-umbrella 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shah-2024-zoster-vaccine-dementia-ma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/filler-2024-post-stroke-cognitive-ma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/arenaza-urquijo-2024-sex-gender-cognitive-resilience 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kikuchi-2024-japan-prs-alzheimer 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/demay-2024-endocrine-society-vitamin-d-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mccartney-2024-vitamin-d-epistemic-humility 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/almutairi-2024-enuresis-prevalence 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gross-2024-spinal-manipulation-pediatric 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/auvinen-2024-proscreen 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/saha-2024-picai-ai-mri 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cornford-2024-eau-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lewis-2024-sperm-stable-american-men 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/stavros-2024-sperm-dna-fragmentation-impact 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/andrabi-2024-sperm-dna-fragmentation-causes 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jp-jua-male-infertility-guideline-2024 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jp-jsmh-male-factor-epidemiology 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/aad-2024-sunscreen-faqs 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/okamura-2024-jas-guidelines-2022 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/winslow-2024-zuranolone-ppd-ma 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/patterson-2024-neurosteroid-therapeutics-ppd 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nakamura-2024-galaxy-circulate-japan 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zheng-2024-ctdna-mrd-meta-analysis 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shaw-2024-serial-ctdna-breast 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nakamura-2024-tissue-free-ctdna-crc 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fukuo-2024-rapamycin-mtor 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/habe-2024-japan-pregnancy-iron-deficiency 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tabata-2024-japan-female-runners-iron 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tang-2024-iron-deficiency-women-health-equity 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/iqbal-2024-fcm-fdi-hypophosphataemia 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kamath-2024-daily-alternate-iron-sr 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gbd-2024-anaemia-women-nutrition-targets 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jastreboff-2024-surmount-1-3year-diabetes-prevention 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/aronne-2024-surmount-4-maintenance 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhao-2024-surmount-cn-chinese 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lawitz-2024-survodutide-cirrhosis-phase1 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/stefanakis-2024-fat-free-mass-weight-loss 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/locatelli-2024-resistance-exercise-incretin 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/melson-2024-obesity-pipeline-review 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jendo-2024-hashimoto-prevalence 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chaker-2024-hyperthyroidism 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lanzolla-2024-graves-trab 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/japanthyroid-2024-diagnosis-guideline 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sankoda-2024-levothyroxine-pregnancy 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/provinciatto-2024-levothyroxine-pregnancy 2024-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lopez-otin-2023-hallmarks-aging 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/waziry-2023-calerie-caloric-restriction 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sun-2023-mcsc-nature 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tai-2023-slow-wave-sleep-dementia 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/aleissa-2023-spironolactone-fphl 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/huang-2023-sleep-blood-pressure-ukbiobank 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lincoff-2023-traverse 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tsuji-2023-enuresis-treatment-resistant 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/voss-2023-overdiagnosis-screening 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kong-2023-mots-c-diabetes-aging 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vandyck-2023-lecanemab-clarity-ad 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ma-2023-akkermansia-aging-mouse 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/prokopidis-2023-probiotics-muscle-meta 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lawrenson-2023-cochrane-nma-myopia 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gut-bacteria-journal-2023-aging-mucosal 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2023-after-school-outdoor-academic 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tang-2023-myopia-nma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/song-q-2023-nmn-safety-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/berven-2023-nr-parkinson-safety 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/damgaard-2023-nr-critical-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yaku-2023-nad-precursors-delivery 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garbarino-2023-sleep-telomere-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pencina-2023-nmn-overweight 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/byrne-2023-biomarker-intervention-frail 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsrm-2023-exosome-recommendation 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/smits-2023-ovarian-aging-mitochondrial 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jds-2023-glp1ra-offlabel-statement 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/baechle-2023-chronic-inflammation-hallmarks 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/monfared-2023-zinc-height-meta 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/soltani-2023-vitamin-d-children-meta 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lederman-2023-fezolinetant 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/olwi-2023-gh-pubertal-timing-meta 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shin-2023-ectopic-mongolian-ndyag 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liguori-2023-physical-activity-pms 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2023-sids-statistics 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/katayama-2023-japanese-infant-cranial-3d 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/deng-2023-sleep-variability-biological-aging 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lincoff-2023-select-semaglutide-obesity-cv 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jiang-2023-time-lapse-ivf 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nowell-2023-antidiabetic-alzheimer-parkinson 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/takeda-2023-pmd-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nishikori-2023-exercise-skin-elasticity 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/beer-2023-pathfinder2-mced 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsog-2023-gynecology-guideline 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/raffaelli-2023-estrogen-withdrawal 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/borcherding-2023-mitochondria-transfer-nature 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mccully-2023-mitochondrial-transplantation-clinical 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tobias-2023-precision-diabetes-consensus 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gupta-2023-fphl-nma-5ari-minoxidil 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kinoshita-ise-2023-hair-loss-advances 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2023-sleep-tracker-validation 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bhasin-2023-traverse-prostate 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pencina-2023-traverse-anemia 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/johnson-2023-fezolinetant-skylight2 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/neal-perry-2023-fezolinetant-skylight4-safety 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pourhadi-2023-mht-dementia-denmark 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/crandall-2023-menopause-management-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/oh-2023 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yamada-2023-vddq-j-screening 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sato-2023-vitamin-d-children-disabilities-japan 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/joseph-2023-tips3-vitamin-d-mortality 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jayedi-2023-vitamin-d-diabetes-mortality 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhu-2023-china-myopia-program-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sims-2023-donanemab-trailblazer 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2023-lecanemab-guideline 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pmda-lecanemab-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rinella-2023-masld-nomenclature-delphi 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vandenplas-2023-espghan-cma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/foodallergy-jp-2023-manual 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2023-migraine-youth-gbd 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2023-gepants-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/handel-2023-osteoporosis-treatment-nma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tran-van-hoi-2023-immune-biomarkers-frailty 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/asilian-2023-oral-vs-topical-minoxidil-aga 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dementia-biomarker-guideline-2023 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lampl-2023-migraine-preventive-nma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sandbank-2023-project-aim 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gonzales-2023-senolytic-alzheimer 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nambiar-2023-senolytic-ipf 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gielen-2023-osteosarcopenia 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shevroja-2023-tbs-consensus 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sadee-2023-pharmacogenomics-comprehensive 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bousman-2023-cyp2d6-antidepressants 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yonkers-2023-sertraline-symptom-onset 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/senevirathna-2023-overdiagnosis-definitions 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/marlow-2023-galleri-psychological-protocol 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wieckowski-2023-mchat-meta 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lenfant-2023-antimuscarinic-bph-ma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liu-2023-letrozole-vs-clomiphene-pcos 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ayers-2023-fracture-prevention-nma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vincent-2023-sids-risk-new-strategies 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/acog-2023-pmd-guideline 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sach-2023-beep-cost-effectiveness 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/demessant-flavigny-2023-ad-microbiome 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/teede-2023-pcos-international-guideline 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shinno-2023-od-leaving-no-one-behind 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rinella-2023-aasld-practice-guidance-nafld 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/younossi-2023-global-burden-liver 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/del-bo-2023-mediterranean-nafld 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/huang-2023-sugar-umbrella-bmj 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ayers-2023-chatgpt-vs-physician-empathy 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/saenz-2023-autonomous-ai-liability 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/guo-2023-mitochondrial-dysfunction-aging 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2024-mitochondrial-hallmarks-crosstalk 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/repka-2023-champ-us-atropine 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nishimoto-2023-urolithin-a-japanese-fmd 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/alshamlan-2023-covid-screen-myopia 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yam-2023-lamp2-atropine-onset 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/barnes-2023-mind-diet-rct-cognitive 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lin-2023-achieve-hearing-cognitive-rct 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yeo-2023-hearing-aids-cognitive-ma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nishizaki-2023-enuresis-japan-cohort 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bretthauer-2023-lifetime-gained 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wei-2023-aua-suo-guideline 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/suemitsu-2023-japan-postpartum-pfd 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dai-2023-postpartum-ui-prevalence 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/levine-2023-sperm-count-global-trend 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shomarufov-2023-varicocelectomy-predictors 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2023-oral-tranexamic-acid-melasma-ma 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lu-2023-arterial-stiffness-global 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/epperson-2023-brexanolone-pooled-rct 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kudo-2023-visiting-restrictions-covid-ppd 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/obikane-2023-paternal-ppd-covid-japan 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chidharla-2023-ctdna-crc-meta-analysis 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/abbosh-2023-tracerx-lung-ctdna 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/doleschal-2023-ctdna-dynamics-mcrc 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/eroglu-2023-ctdna-melanoma-monitoring 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mannick-lamming-2023-rapamycin-mtor 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kaeberlein-2023-rapamycin-mtor 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/simon-2023-ospemifene-network-meta 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ohta-2023-japan-gsm-survey 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/christmas-2023-mht-urinary-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/agrawal-2023-vaginal-estrogen-breast-cancer 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ozaki-2023-genja-vva-luts 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/munro-2023-heavy-menstrual-bleeding-iron 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hansen-2023-iv-iron-pregnancy-rct 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/von-siebenthal-2023-alternate-day-iron-rct 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garvey-2023-surmount-2-tirzepatide-t2dm 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jastreboff-2023-retatrutide-phase2 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/karakasis-2023-oral-glp1-meta-analysis 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jasso-2023-obesity-drug-statement 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/conrad-2023-autoimmune-sex 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2023-hyperthyroidism-review 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garofalo-2023-iron-thyroid 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/soheili-nezhad-2023-thyroid-psychiatric 2023-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sugden-2022-pace-dementia 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/belsky-2022-dunedinpace 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/miner-2022-sleep-healthy-aging-review 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lin-2022-stress-telomere-mechanisms 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/buttet-2022-lifestyle-telomere-meta 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ling-2022-gut-microbiota-aging-review 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/aljumaah-2022-probiotics-mci-rct 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yi-2022-nmn-dose-response 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2022-menopause-survey 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kwon-2022-admsc-exosome-hair 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jua-2022-loh-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/khavinson-2022-sasp-cardiovascular 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/moon-2022-sids-aap 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fard-2022-inflammation-cognition-elderly 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsso-2022-obesity-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/teissier-2022-inflammageing-immunosenescence 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tiranini-2022-pmdd-advances 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fu-z-2022-diabetes-nocturia-ma 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/di-giosia-2022-nutrition-inflammaging 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/horne-2022-endometriosis-bmj 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/becker-2022-eshre-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jbcag-2022-aesthetic-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zuberbier-2022-omalizumab-food-allergy 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nappi-2022-estrogens-menstrual-migraine 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ogunlaja-2022-headache-treatment-update 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mccully-2022-mitochondrial-transplantation-organ-rescue 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jayasena-2022-sfe-trt-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/loh-2022-japan-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/makarious-2022-prenatal-substance-sids 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/blair-2022-bed-sharing-sids 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/carroll-2022-sleep-epigenetic-aging 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shen-2022-liquid-biopsy-sr-ma 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-oliveira-2022-prp-female-aga 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gupta-2022-oral-minoxidil-finasteride-dutasteride 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/taniguchi-2022-trt-erectile-function-meta 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/akehi-2022-loh-questionnaire-japan 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/logan-2022-leap-eat-pooled 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/groti-antonic-2022-testosterone-bone 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/an-2022-micronutrients-cv-risk 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tsugawa-2022-vitamin-d-japanese-young-women 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nascimento-2022-ldom-025-vs-1mg-fphl 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-silva-2022-eaaci-food-immunotherapy 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/carlini-2022-pmdd-scoping 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/motta-2022-inflammaging-osteoarthritis 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mohammadi-2022-omega3-pms 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/xing-2022-exercise-inflammaging-t2dm 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/canelo-aybar-2022-mammography-interval 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2022-cyp2c19-clopidogrel 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jma-2022-genetic-testing-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/potnis-2022-fda-ai-breast-cancer 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mulraney-2022-adhd-screening 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/salari-2022-asd-global-prevalence 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/paller-2022-dupilumab-preschool 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kelleher-2022-emollient-prevention-cochrane 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wollenberg-2022-euroguide-ad-systemic 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/boris-2022-pediatric-pots-review 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mozes-2022-vcte-fib4-auroc 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nams-2022-hormone-therapy-position 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-almeida-2022-aldh2-japanese-fitness 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lim-2022-exercise-mitochondria-cvd-meta 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/singh-2021-urolithin-a-bioavailability 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/singh-2022-urolithin-a-middle-aged 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liu-2022-urolithin-a-older-adults 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bao-2022-hal-stellest-rct 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jiang-2022-rlrl-myopia-rct 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/iso-markku-2022-physical-activity-dementia-ma 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bouillon-2022-vitamin-d-supplementation-review 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tong-2022-enuresis-tuina 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kannan-2022-enuresis-acupuncture 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/toale-2022-enuresis-ptens 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sawai-2022-japan-pfd-healthcare-workers 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-ligny-2022-antioxidants-male-subfertility 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lantsberg-2022-microtese-azoospermia-outcomes 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ghalayini-2022-repeated-microtese-azoospermia 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jp-mhlw-fertility-insurance-2022 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liu-2022-postpartum-depression-prevalence-ma 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/park-2022-epds-predictive-validity-ma 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wald-2022-brexanolone-breast-milk-pk 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/matsuo-2022-sleep-duration-ppd-japan 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tie-2022-dynamic-ctdna-adjuvant 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pascual-2022-esmo-ctdna-recommendations 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/banys-2022-liquid-biopsy-mbc-review 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/filippini-2022-co2-laser-meta 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jastreboff-2022-surmount-1-tirzepatide 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wilding-2022-step1-extension-rebound 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jasso-2022-obesity-guideline 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/toloza-2022-thyroid-preeclampsia 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2022-pregnancy-postpartum-thyroid 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yokomichi-2022-maternal-thyroid-infant 2022-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vano-galvan-2021-ldom-safety 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fitzgerald-2021-epigenetic-age-reversal 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rosenberg-2021-hair-graying-reversal 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bayoumy-2021-wearable-cardiovascular-review 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lu-2021-prs-short-stature-prediction 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/duggan-2021-vosoritide-approval-review 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsprs-2021-ectopic-mongolian-guideline 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/funahashi-2021-pediatric-laser-mongolian 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kwon-2021-bioage-toolkit 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/taylor-2021-endometriosis-systemic 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wilmanski-2021-gut-microbiome-aging 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/brin-2021-botox-cochrane 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vetvik-2021-menstrual-migraine-recognition 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/stahn-2021-bed-sharing-eu-guidelines 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2021-laser-ota-meta 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jullien-2021-sids-prevention 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/larson-2021-mtb-clinical-outcomes 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ginsburg-2021-ignite-pragmatic-rct 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/okinaka-2021-shiga-opportunistic 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gentile-2021-lllt-hair-loss 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ibrahim-2021-pumpkinseed-vs-minoxidil-fphl 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kim-2021-trt-metabolic-meta 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-2021-mht-umbrella-review 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nappi-2021-vms-global-survey 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wanigatunga-2021-sturdy-vitamin-d-falls 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jolliffe-2021-vitamin-d-respiratory-infections 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ito-2021-childhood-maltreatment-pms 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jspaci-2021-food-allergy-guideline 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jns-2021-headache-guideline 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jhs-2021-cgrp-guideline 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/besiroglu-2021-ed-cvd-umbrella 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hart-2021-dietary-patterns-inflammation 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ling-2021-gut-microbiota-aging 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/santoro-2021-immunosenescence-longevity 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-wit-2021-coc-pms-nma 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/guariento-2021-mitochondrial-transplantation-ecmo 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ikeda-2021-mitochondria-rich-evs-cardiac 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/salonia-2021-eau-male-sexual-dysfunction 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tanner-2021-asd-early-symptoms 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/faraone-2021-adhd-consensus 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/salari-2021-osteoporosis-global-prevalence 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yan-2021-pmdd-suicidality 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tsuge-2021-atopic-march-insights 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/koh-2021-ad-skin-microbiome 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/eichenfield-2021-abrocitinib-jade-teen 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vernino-2021-pots-nih-consensus 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mathias-2021-eds-hsd-dysautonomia 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rudnicka-2021-chronic-inflammation-pcos 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tokushige-2021-jsge-jsh-nafld-guideline 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wolffsohn-2021-imi-reports-digest 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/purnomo-2021-enuresis-alarm-desmopressin 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nishizaki-2021-enuresis-nocturnal-polyuria 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/batmani-2021-ui-prevalence-elderly 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/takahashi-2021-female-luts-guideline 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/boitrelle-2021-who-sixth-edition-semen 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pyrgidis-2021-antioxidants-varicocele 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/carson-2021-infertility-diagnosis-management 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/passeron-2021-photoprotection-phototype-panel 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/krutmann-2021-daily-photoprotection-exposome 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lin-2021-picosecond-laser-melasma-asian 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wright-2021-orion-inclisiran-pooled 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2021-paternal-ppd-ma 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zavridou-2021-ctc-exosome-prostate 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mannick-2021-rapamycin-mtor 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-2021-rapamycin-mtor 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ogasawara-2021-rapamycin-mtor 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chen-2021-estrogen-ruti-meta 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2021-co2-laser-sham-rct 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/garcia-casal-2021-ferritin-cochrane 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shin-2021-fcm-iron-sucrose-meta-analysis 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/xu-2021-hashimoto-ptc-outcomes 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/oh-2021-thyroid-cancer-overdiagnosis 2021-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhang-2020-stress-hair-graying 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/panchaprateep-2020-oral-minoxidil-5mg 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kumar-2020-premature-graying-review 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chaput-2020-sleep-timing-consistency-review 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/badal-2020-gut-microbiome-longevity-review 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ghosh-2020-intestinal-barrier-lps 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/galicia-garcia-2020-t2dm-pathophysiology 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-koning-2020-nelson-ldct 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/huey-2020-vitamin-d-growth-cochrane 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mishra-2020-covid-smartwatch 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dubol-2020-pmdd-neuroimaging 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nedergaard-2020-glymphatic-dementia 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/de-vries-2020-cgrp-5ht-triptans 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tsimberidou-2020-precision-cancer-evolution 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/luchini-2020-mtb-practical-review 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/manson-2020-whi-lessons 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chlebowski-2020-whi-breast-cancer-20yr 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/okereke-2020-vital-dep-depression 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/leboff-2020-vital-falls 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/thanapluetiwong-2020-vitamin-d-fall-fracture-ma 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cao-2020-pms-postpartum-depression 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cena-2020-glp1-obesity-pcos-infertility 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sanchez-garrido-2020-androgen-metabolic-pcos 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/he-2020-bone-muscle-crosstalk 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/simpson-2020-abrocitinib-jade-mono1 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/saito-2020-hirosaki-asd 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/al-sharefi-2020-hypogonadism-guidelines-comparison 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nams-2020-gsm-position 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/carucci-2020-mph-growth 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/osibogun-2020-pcos-cardiovascular-risk 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shojaa-2020-resistance-exercise-bmd 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sundstrom-poromaa-2020-progesterone 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yang-2020-atopic-march 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hasan-2020-pots-medication-systematic-review 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ishii-2020-inoh-nirs-cerebral-autoregulation 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/go-2020-orthostatic-headache-children-nirs 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lam-2020-dims-spectacles 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jsog-2020-pgta-clinical-research 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/haarman-2020-myopia-complications-meta 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/livingston-2020-lancet-dementia-prevention-12factors 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ninomiya-2020-jpsc-ad-japan-cohort 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/neveus-2020-enuresis-iccs-guideline 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/liu-2020-allergic-rhinitis-sleep 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bugge-2020-pessary-pop 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/akervall-2020-childbirth-pop 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hagen-2020-pfmt-biofeedback-opal 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/woodley-2020-pfmt-antenatal 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/birowo-2020-varicocele-repair-pregnancy 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/campiche-2020-blue-light-pigmentation-rct 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nidorf-2020-lodoco2-colchicine 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hooper-2020-saturated-fat-cochrane 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/levis-2020-epds-accuracy-ipd-meta-analysis 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nishigori-2020-paternal-ppd-japan-jecs 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tachibana-2020-community-mental-health-ppd-nagano 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kubota-2020-suicidal-ideation-perinatal-japan 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/radovich-2020-ctdna-ctc-tnbc 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/selvarani-2020-rapamycin-mtor 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/who-2020-ferritin-iron-status-guideline 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chen-2020-levothyroxine-hypothyroidism 2020-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kirkland-2019-senolytics-humans 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lu-2019-grimage 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/barcena-2019-fmt-progeroid 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zheng-2019-aerobic-exercise-inflammation 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/furman-2019-chronic-inflammation 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/swanson-2019-nlrp3-inflammasome 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fda-2019-exosome-safety 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhou-2019-dutasteride-vs-finasteride 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/furman-2019-chronic-inflammation-disease 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/anvari-2019-ige-food-allergy-review 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/perez-2019-apple-heart-study 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/manson-2019-vital-vitamin-d-cancer-cvd 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chu-2019-pace-peanut-oit 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2019-weaning-guide 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sanchez-garcia-2019-asd-toddler-screening 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cruz-jentoft-2019 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wolraich-2019-aap-adhd-guideline 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/horne-2019-sids-perspectives 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lim-2019-metabolic-syndrome-pcos 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yao-2019-vitd-calcium-fracture-prevention 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yam-2019-lamp-phase1 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/estebanez-2019-resistance-mitochondria-elderly 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bullimore-2019-each-diopter-matters 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/williamson-2019-sprint-mind-bp-dementia 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/who-2019-cognitive-decline-prevention-guideline 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hugosson-2019-erspc-16yr 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nice-2019-ui-pop-ng123 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schneider-2019-inorganic-uv-filters 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/libby-2019-atherosclerosis-primer 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/frieder-2019-pharmacotherapy-ppd-review 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/didonato-2019-ospemifene-efficacy-meta 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/didonato-2019-ospemifene-safety-meta 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lopez-2019-rls-iron-deficiency 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/krawiec-2019-stfr-iron-deficiency 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bekkering-2019-subclinical-hypothyroidism 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rayman-2019-nutrition-thyroid 2019-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/levine-2018-phenoage 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/edf-2018-aga-guideline 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wolf-2018-trauma-methylation-age 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ferrucci-2018-inflammageing 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fulop-2018-immunosenescence-inflammaging 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2018-cgas-sting 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/franceschi-2018-inflammaging-immune-metabolic 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/uspstf-2018-prostate-screening 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2018-ghd-diagnostic-guide 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/giuliani-2018-mitochondria-inflammaging 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/song-2018-gnrha-gh-combination-meta 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gurau-2018-anti-senescence-nutraceuticals 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rasmussen-2018-glymphatic-disorders 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/matsumoto-2018-egg-eczema-prevention 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bhasin-2018-endocrine-society-guideline 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bright-2018-sids-neuropathology 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/benveniste-2018-glymphatic-aging 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/snyder-2018-ttrials-lessons 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/oki-2018-japan-psa-trend 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yeap-2018-ttrials-clinical-implications 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jssfm-2018-ed-guideline 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/amstutz-2018-dpyd-fluoropyrimidine 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ilic-2018-psa-screening-srma 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/manabe-2018-japan-hair-loss-guideline 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/azziz-2018-pcos-comprehensive-review 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cortese-2018-adhd-medications-nma 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fu-levine-2018-pots-exercise 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gilling-2018-water-aquablation-rct 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2018-physician-act-17-ai-notification 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/amed-2018-endobrain-approval-japan 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chang-2018-enuresis-uroflowmetry 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/peng-2018-enuresis-alarm-desmopressin 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/martin-2018-cap-trial 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kasivisvanathan-2018-precision 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/horvath-raj-2018-clock-theory 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/blomquist-2018-delivery-mode-pfd 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dumoulin-2018-pfmt-ui-cochrane 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/salas-huetos-2018-nutrients-sperm-quality 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hirata-2018-extreme-hdl-epoch-japan 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schwartz-2018-odyssey-alirocumab 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/estruch-2018-predimed-mediterranean 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shorey-2018-postpartum-depression-healthy-mothers 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ncchd-2018-maternal-suicide-japan 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mannick-2018-rapamycin-mtor 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kraig-2018-rapamycin-mtor 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/justice-2018-rapamycin-mtor 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kahaly-2018-eta-graves 2018-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/al-niaimi-2017-vitamin-c-skin 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ridker-2017-canakinumab-lung-cancer 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ridker-2017-cantos-canakinumab 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/xiong-2017-outdoor-meta 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jda-2017-aga-guideline 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/calder-2017-low-grade-inflammation-ageing 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/collett-2017-plagiocephaly-development-36m 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/saito-2017-childhood-migraine-od 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ying-2017-gnrha-cpp-height 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/macgregor-2017-migraine-menopause-hrt 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/resnick-2017-ttrials-cognitive 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/thevaranjan-2017-microbial-dysbiosis 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fleming-2017-prone-sids-mechanism 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/emani-2017-first-human-mitochondrial-transplantation 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jua-2017-bph-guideline 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/saag-2017-romosozumab-arch 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bone-2017-denosumab-freedom-10yr 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/zhao-2017-calcium-vitd-fracture-jama 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sparks-2017-calerie-mitochondrial-function 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ahmed-2017-promis-mri 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/neveus-2017-enuresis-pathogenesis 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/levine-2017-sperm-count-western-trend 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/takahashi-2017-japanese-pigment-spots-age 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sabatine-2017-fourier-evolocumab 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/muchanga-2017-gynecological-risk-ppd-jecs 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mhlw-2017-maternal-health-checkup-epds 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jaog-2017-postpartum-depression-prevalence 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/yokoi-2017-idna-fatigue-meta-analysis 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/breymann-2017-fcm-pregnancy-fer-asap 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/stoffel-2017-alternate-day-iron-absorption 2017-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/biagi-2016-longevity-gut 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/flannery-2016-cns-plagiocephaly 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/adhikari-2016-gwas-hair-features 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/barzilai-2016-tame-metformin 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/irwin-2016-sleep-inflammation-meta 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/snyder-2016-ttrials-testosterone 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/van-zuuren-2016-fphl-cochrane 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lopez-otin-2016-metabolic-longevity 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/marso-2016-leader-liraglutide-cv 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/corona-2016-testosterone-body-composition 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/marso-2016-sustain6-semaglutide-cv 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/du-toit-2016-leap-on-avoidance 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/perkin-2016-eat-feasibility 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/natsume-2016-petit-egg 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/perkin-2016-eat-allergenic-foods 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mccully-2016-mitochondrial-transplantation-review 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cosman-2016-romosozumab-frame 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2016-midodrine-pots-children 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/chia-2016-atom2-5year 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tideman-2016-axial-length-visual-impairment 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/li-2016-pfmt-pop 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/deligiannidis-2016-gaba-nas-peripartum 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tie-2016-ctdna-mrd-stage2-colon 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/strong-2016-rapamycin-mtor 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mukhopadhyay-2016-rapamycin-mtor 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/labrie-2016-intravaginal-dhea-rct 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ross-2016-ata-hyperthyroidism 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/maraka-2016-subclinical-pregnancy 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wang-2016-seaweed-thyroid-cancer 2016-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/marioni-2015-methylation-mortality 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/minihane-2015-diet-inflammation 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cunningham-2015-ttrials-baseline 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ostan-2015-inflammaging-mediterranean-diet 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gupta-2015-minoxidil-topical-meta 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/oyetakin-white-2015-sleep-skin-aging 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/du-toit-2015-leap-peanut-allergy 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/adams-2015-sids-clinical-review 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/leong-2015 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/leder-2015-data-switch-sequential 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sigurgeirsson-2015-pimecrolimus-5year 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/jspp-guideline-book-2015 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vilar-gomez-2015-weight-loss-nash 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ngandu-2015-finger-multidomain-rct 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lee-2015-mots-c-discovery 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/morris-2015-mind-diet-cognitive-decline 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tanaka-2015-ipl-solar-lentigines-japanese 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cannon-2015-improve-it-ezetimibe 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ctt-2015-sex-specific-meta 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mons-2015-smoking-cessation-chances 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schiller-2015-reproductive-hormones-ppd-review 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/milgrom-2015-cbt-sertraline-ppd-rct 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/moretti-2015-hepcidin-iron-absorption 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/japanese-iron-society-2015-anemia-guideline 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/uspstf-2015-thyroid-screening 2015-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/morrisette-thomas-2014-inflammaging-complexity 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/van-wijk-2014-helmet-rct-bmj 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kitagawa-2014-japan-age-psa 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/franceschi-2014-inflammaging-definition 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schroder-2014-erspc-13yr 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sato-2014-y-chromosome-japanese-semen 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/battie-2014-uva-photoaging-skintypes 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/iannacone-2014-sunscreen-cancer-photoaging-review 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mannick-2014-rapamycin-mtor 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/sawada-2014-japan-idna-fatigue 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/caturegli-2014-hashimoto-diagnosis 2014-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/horvath-2013-dna-methylation-age 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hannum-2013-methylation-aging-rate 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ornish-2013-lifestyle-telomere 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hughes-2013-sunscreen-aging 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/heneka-2013-nlrp3-alzheimer 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gupta-2013-mongolian-spot-importance 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/mawji-2013-plagiocephaly-incidence 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gotzsche-2013-mammography-cochrane 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ilic-2013-psa-cochrane 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vlachopoulos-2013-ed-cv-mortality-meta 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/masuzawa-2013-mitochondrial-transplantation-heart 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hughes-2013-sunscreen-photoaging-rct 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/apa-2013-dsm5-peripartum-onset 2013-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/pedersen-2012-muscle-secretory-organ 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bernardes-de-jesus-2012-telomerase-gene-therapy 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cfa-sids-diagnostic-guideline 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nehra-2012-princeton-iii 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/harari-2012-enuresis-review 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kamide-2012-photoaging-jda-review 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/vaucher-2012-iron-fatigue-rct 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/michikawa-2012-seaweed-thyroid-cancer 2012-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nlst-2011-ldct-lung 2011-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/dong-2011-ed-cvd-meta 2011-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/schmitt-2011-proactive-therapy-meta 2011-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/okosieme-2011-replacement-adequacy 2011-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/coppe-2010-sasp 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wu-2010-emas-hypogonadism 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/speltz-2010-plagiocephaly-development 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shiseido-2010-japanese-skin-aging 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/duncan-2010-sids-serotonin 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/katabami-2010-ft-metabolic-syndrome-japan 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ctt-2010-ldl-lowering-meta 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bachmann-2010-ospemifene-rct 2010-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kikuchi-2009-retinol-japanese-rct 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/odonovan-2009-pessimism-telomere 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/morgentaler-2009-testosterone-prostate-saturation 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/wood-2009-h2o2-hair-graying 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/rosenbloom-2009-iss-review 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hamashima-2009-japan-ncc-guideline 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cummings-2009-denosumab-freedom 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/tanaka-2009-jp-od-guideline 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/asakura-2009-japanese-lifestyle-skin-aging 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/harrison-2009-rapamycin-mtor 2009-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ornish-2008-telomerase-lifestyle 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fournier-2008-progesterone-breast-cancer 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/van-vlimmeren-2008-plagiocephaly-pt-rct 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kagami-2008-alexandrite-laser-mongolian 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/buechner-2008-uva-uvb-ira-mmp 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/detrano-2008-cac-mesa 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/ridker-2008-jupiter-rosuvastatin 2008-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hewitson-2007-fobt-cochrane 2007-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cosgrove-2007-diet-skin-aging 2007-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lyles-2007-zoledronic-acid-horizon-rft 2007-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/gruber-2007-photocarcinogenesis 2007-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lorenz-2007-carotid-imt-meta 2007-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/olsen-2006-dutasteride-landmark 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kikuchi-2006-ectopic-mongolian-textbook 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shores-2006-low-testosterone-mortality 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/burnett-2006-nitric-oxide-ed 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/esposito-2006-mediterranean-diet-ed 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/homma-2006-luts-japan-epidemiology 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/trost-2006-iron-deficiency-hair-loss 2006-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bissett-2005-niacinamide-aging 2005-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nishimura-2005-mcsc-maintenance 2005-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kauser-2005-mc1r-hair-follicle 2005-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/montorsi-2005-artery-size-hypothesis 2005-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/petersen-2005-exercise-anti-inflammatory 2005-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/bissett-2005-niacinamide-facial-rct 2005-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/lucky-2004-minoxidil-5vs2-fphl 2004-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/epel-2004-stress-telomere 2004-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/esposito-2004-lifestyle-ed-rct 2004-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nicolosi-2003-ed-four-countries 2003-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/hanson-2003-melanocytosis-lysosomal 2003-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/honma-2003-japan-incontinence-prevalence 2003-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/humbert-2003-topical-vitamin-c-rct 2003-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/feldman-2002-testosterone-age-trends 2002-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/finkelstein-2002-gh-iss-meta 2002-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/neer-2001-teriparatide-rct 2001-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kang-2001-photoaging-review 2001-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/franceschi-2000-inflammaging 2000-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/nagashima-1999-skin-phototype-wrinkles 1999-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/kaufman-1998-finasteride 1998-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/downs-1998-afcaps-texcaps-lovastatin 1998-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/fisher-1997-uv-mmp-collagen 1997-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/shepherd-1995-woscops-pravastatin 1995-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/griffiths-1994-tretinoin-asian-pigmentation 1994-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/scandinavian-1994-4s-simvastatin 1994-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/raz-1993-vaginal-estriol-ruti-rct 1993-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/uchida-1992-japanese-women-iron-deficiency 1992-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/anderson-1983-selective-photothermolysis 1983-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/evidence/cordova-1981-mongolian-spot-ethnic 1981-01-01T00:00:00.000Z monthly 0.5 https://igaku-yorozu.com/consultation 2026-07-05T12:35:02.115Z weekly 0.9 https://igaku-yorozu.com/pricing 2026-07-05T12:35:02.115Z monthly 0.8 https://igaku-yorozu.com/search 2026-07-05T12:35:02.115Z monthly 0.5 https://igaku-yorozu.com/qa 2026-07-05T12:35:02.115Z monthly 0.5 https://igaku-yorozu.com/contact 2026-07-05T12:35:02.115Z yearly 0.3 https://igaku-yorozu.com/about 2026-07-05T12:35:02.115Z monthly 0.5 https://igaku-yorozu.com/about/editorial-policy 2026-07-05T12:35:02.115Z monthly 0.6 https://igaku-yorozu.com/disclaimer 2026-07-05T12:35:02.115Z yearly 0.3 https://igaku-yorozu.com/terms 2026-07-05T12:35:02.115Z yearly 0.3 https://igaku-yorozu.com/privacy 2026-07-05T12:35:02.115Z yearly 0.3